Zeiser R, Blazar BR. Acute Graft-versus-Host Illness – Biologic course of, prevention, and remedy. N Engl J Med. 2017;377(22):2167–79.
Reshef R, Saber W, Bolaños-Meade J, Chen G, Chen YB, Ho VT, Ponce DM, Nakamura R, Martens MJ, Hansen JA, Levine JE, Acute GVHD. Prognosis and adjudication in a multicenter trial: A report from the BMT CTN 1202 biorepository research. J Clin Oncology: Official J Am Soc Clin Oncol. 2021;39(17):1878–87.
Greinix HT, Eikema DJ, Koster L, Penack O, Yakoub-Agha I, Montoto S, Chabannon C, Styczynski J, Nagler A, Robin M, Robinson S, Chalandon Y, Mikulska M, Schönland S, Peric Z, Ruggeri A, Lanza F, De Wreede LC, Mohty M, Basak GW, Kröger N. Improved end result of sufferers with graft-versus-host illness after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file research. Haematologica. 2022;107(5):1054–63.
Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Acute graft-versus-host illness. Nat Opinions Illness Primers. 2023;9(1):27.
Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host illness. Lancet (London England). 2009;373(9674):1550–61.
Chakraverty R, Teshima T. Graft-versus-host illness: a dysfunction of tissue regeneration and restore. Blood. 2021;138(18):1657–65.
S ELA, Mäger I, Breakefield XO, Wooden MJ. Extracellular vesicles: biology and rising therapeutic alternatives. Nat Rev Drug Discov. 2013;12(5):347–57.
Théry, C.; Witwer, Ok. W.; Aikawa, E.; Alcaraz, M. J.; Anderson, J. D.; Andriantsitohaina,R.; Antoniou, A.; Arab, T.; Archer, F.; Atkin-Smith, G. Ok.; Ayre, D. C.; Bach, J.M.; Bachurski, D.; Baharvand, H.; Balaj, L.; Baldacchino, S.; Bauer, N. N.; Baxter,A. A.; Bebawy, M.; Beckham, C.; Bedina Zavec, A.; Benmoussa, A.; Berardi, A. C.; Bergese,P.; Bielska, E.; Blenkiron, C.; Bobis-Wozowicz, S.; Boilard, E.; Boireau, W.; Bongiovanni,A.; Borràs, F. E.; Bosch, S.; Boulanger, C. M.; Breakefield, X.; Breglio, A. M.; Brennan,M.; Brigstock, D. R.; Brisson, A.; Broekman, M. L.; Bromberg, J. F.; Bryl-Górecka,P.; Buch, S.; Buck, A. H.; Burger, D.; Busatto, S.; Buschmann, D.; Bussolati, B.;Buzás, E. I.; Byrd, J. B.; Camussi, G.; Carter, D. R.; Caruso, S.; Chamley, L. W.;Chang, Y. T.; Chen, C.; Chen, S.; Cheng, L.; Chin, A. R.; Clayton, A.; Clerici, S.P.; Cocks, A.; Cocucci, E.; Coffey, R. J.; Cordeiro-da-Silva, A.; Sofa, Y.; Coumans,F. A.; Coyle, B.; Crescitelli, R.; Criado, M. F.; D’Souza-Schorey, C.; Das, S.; Datta Chaudhuri, A.; de Candia, P.; De Santana, E. F.; De Wever, O.; Del Portillo, H. A.;Demaret, T.; Deville, S.; Devitt, A.; Dhondt, B.; Di Vizio, D.; Dieterich, L. C.;Dolo, V.; Dominguez Rubio, A. P.; Dominici, M.; Dourado, M. R.; Driedonks, T. A.;Duarte, F. V.; Duncan, H. M.; Eichenberger, R. M.; Ekström, Ok.; El Andaloussi, S.;Elie-Caille, C.; Erdbrügger, U.; Falcón-Pérez, J. M.; Fatima, F.; Fish, J. E.; Flores-Bellver,M.; Försönits, A.; Frelet-Barrand, A.; Fricke, F.; Fuhrmann, G.; Gabrielsson, S.;Gámez-Valero, A.; Gardiner, C.; Gärtner, Ok.; Gaudin, R.; Gho, Y. S.; Giebel, B.; Gilbert,C.; Gimona, M.; Giusti, I.; Goberdhan, D. C.; Görgens, A.; Gorski, S. M.; Greening,D. W.; Gross, J. C.; Gualerzi, A.; Gupta, G. N.; Gustafson, D.; Handberg, A.; Haraszti,R. A.; Harrison, P.; Hegyesi, H.; Hendrix, A.; Hill, A. F.; Hochberg, F. H.; Hoffmann,Ok. F.; Holder, B.; Holthofer, H.; Hosseinkhani, B.; Hu, G.; Huang, Y.; Huber, V.;Hunt, S.; Ibrahim, A. G.; Ikezu, T.; Inal, J. M.; Isin, M.; Ivanova, A.; Jackson,H. Ok.; Jacobsen, S.; Jay, S. M.; Jayachandran, M.; Jenster, G.; Jiang, L.; Johnson,S. M.; Jones, J. C.; Jong, A.; Jovanovic-Talisman, T.; Jung, S.; Kalluri, R.; Kano,S. I.; Kaur, S.; Kawamura, Y.; Keller, E. T.; Khamari, D.; Khomyakova, E.; Khvorova,A.; Kierulf, P.; Kim, Ok. P.; Kislinger, T.; Klingeborn, M.; Klinke, D. J., 2nd; Kornek,M.; Kosanović, M. M.; Kovács Á, F.; Krämer-Albers, E. M.; Krasemann, S.; Krause, M.;Kurochkin, I. V.; Kusuma, G. D.; Kuypers, S.; Laitinen, S.; Langevin, S. M.; Languino,L. R.; Lannigan, J.; Lässer, C.; Laurent, L. C.; Lavieu, G.; Lázaro-Ibáñez, E.; Le Lay, S.; Lee, M. S.; Lee, Y. X. F.; Lemos, D. S.; Lenassi, M.; Leszczynska, A.; Li,I. T.; Liao, Ok.; Libregts, S. F.; Ligeti, E.; Lim, R.; Lim, S. Ok.; Linē, A.; Linnemannstöns,Ok.; Llorente, A.; Lombard, C. A.; Lorenowicz, M. J.; Lörincz Á, M.; Lötvall, J.; Lovett,J.; Lowry, M. C.; Loyer, X.; Lu, Q.; Lukomska, B.; Lunavat, T. R.; Maas, S. L.; Malhi,H.; Marcilla, A.; Mariani, J.; Mariscal, J.; Martens-Uzunova, E. S.; Martin-Jaular,L.; Martinez, M. C.; Martins, V. R.; Mathieu, M.; Mathivanan, S.; Maugeri, M.; McGinnis,L. Ok.; McVey, M. J.; Meckes, D. G., Jr.; Meehan, Ok. L.; Mertens, I.; Minciacchi, V.R.; Möller, A.; Møller Jørgensen, M.; Morales-Kastresana, A.; Morhayim, J.; Mullier,F.; Muraca, M.; Musante, L.; Mussack, V.; Muth, D. C.; Myburgh, Ok. H.; Najrana, T.;Nawaz, M.; Nazarenko, I.; Nejsum, P.; Neri, C.; Neri, T.; Nieuwland, R.; Nimrichter,L.; Nolan, J. P.; Nolte-‘t Hoen, E. N.; Noren Hooten, N.; O’Driscoll, L.; O’Grady,T.; O’Loghlen, A.; Ochiya, T.; Olivier, M.; Ortiz, A.; Ortiz, L. A.; Osteikoetxea,X.; Østergaard, O.; Ostrowski, M.; Park, J.; Pegtel, D. M.; Peinado, H.; Perut, F.;Pfaffl, M. W.; Phinney, D. G.; Pieters, B. C.; Pink, R. C.; Pisetsky, D. S.; Pogge von Strandmann, E.; Polakovicova, I.; Poon, I. Ok.; Powell, B. H.; Prada, I.; Pulliam,L.; Quesenberry, P.; Radeghieri, A.; Raffai, R. L.; Raimondo, S.; Rak, J.; Ramirez,M. I.; Raposo, G.; Rayyan, M. S.; Regev-Rudzki, N.; Ricklefs, F. L.; Robbins, P. D.;Roberts, D. D.; Rodrigues, S. C.; Rohde, E.; Rome, S.; Rouschop, Ok. M.; Rughetti,A.; Russell, A. E.; Saá, P.; Sahoo, S.; Salas-Huenuleo, E.; Sánchez, C.; Saugstad,J. A.; Saul, M. J.; Schiffelers, R. M.; Schneider, R.; Schøyen, T. H.; Scott, A.;Shahaj, E.; Sharma, S.; Shatnyeva, O.; Shekari, F.; Shelke, G. V.; Shetty, A. Ok.;Shiba, Ok.; Siljander, P. R.; Silva, A. M.; Skowronek, A.; Snyder, O. L., 2nd; Soares,R. P.; Sódar, B. W.; Soekmadji, C.; Sotillo, J.; Stahl, P. D.; Stoorvogel, W.; Stott,S. L.; Strasser, E. F.; Swift, S.; Tahara, H.; Tewari, M.; Timms, Ok.; Tiwari, S.;Tixeira, R.; Tkach, M.; Toh, W. S.; Tomasini, R.; Torrecilhas, A. C.; Tosar, J. P.;Toxavidis, V.; Urbanelli, L.; Vader, P.; van Balkom, B. W.; van der Grein, S. G.;Van Deun, J.; van Herwijnen, M. J.; Van Keuren-Jensen, Ok.; van Niel, G.; van Royen,M. E.; van Wijnen, A. J.; Vasconcelos, M. H.; Vechetti, I. J., Jr.; Veit, T. D.; Vella,L. J.; Velot, É.; Verweij, F. J.; Vestad, B.; Viñas, J. L.; Visnovitz, T.; Vukman,Ok. V.; Wahlgren, J.; Watson, D. C.; Wauben, M. H.; Weaver, A.; Webber, J. P.; Weber,V.; Wehman, A. M.; Weiss, D. J.; Welsh, J. A.; Wendt, S.; Wheelock, A. M.; Wiener,Z.; Witte, L.; Wolfram, J.; Xagorari, A.; Xander, P.; Xu, J.; Yan, X.; Yáñez-Mó, M.;Yin, H.; Yuana, Y.; Zappulli, V.; Zarubova, J.; Žėkas, V.; Zhang, J. Y.; Zhao, Z.;Zheng, L.; Zheutlin, A. R.; Zickler, A. M.; Zimmermann, P.; Zivkovic, A. M.; Zocco,D.; Zuba-Surma, E. Ok., Minimal info for research of extracellular vesicles 2018(MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 tips. Journal of extracellular vesicles 2018, 7 (1), 1535750.
Bai L, Shao H, Wang H, Zhang Z, Su C, Dong L, Yu B, Chen X, Li X, Zhang X. Results of mesenchymal stem Cell-Derived exosomes on experimental autoimmune uveitis. Sci Rep. 2017;7(1):4323.
Wu X, Liu Y, Wei W, Liu ML. Extracellular vesicles in autoimmune vasculitis – Little Dirts mild the hearth in blood vessels. Autoimmun Rev. 2019;18(6):593–606.
Greening DW, Xu R, Ale A, Hagemeyer CE, Chen W. Extracellular vesicles as subsequent era immunotherapeutics. Sem Most cancers Biol. 2023;90:73–100.
Fujii S, Miura Y. Immunomodulatory and regenerative results of MSC-Derived extracellular vesicles to deal with acute GVHD. Stem Cells. 2022;40(11):977–90.
Yu D, Li Y, Wang M, Gu J, Xu W, Cai H, Fang X, Zhang X. Exosomes as a brand new frontier of most cancers liquid biopsy. Mol Most cancers. 2022;21(1):56.
Pegtel DM, Gould SJ, Exosomes. Annu Rev Biochem. 2019;88:487–514.
Buzas EI. The roles of extracellular vesicles within the immune system. Nat Rev Immunol. 2023;23(4):236–50.
Carneiro TX, Marrese DG, Santos MGD, Gonçalves MV, Novis YAS, Rizzatti EG, Rocha V, Sandes AF, de Lacerda MP, Arrais-Rodrigues C. Circulating Extracellular Vesicles as a Predictive Biomarker for Acute Graft-Versus-Host Illness. Experimental hematology 2022.
Nagasawa M, Mitsuiki N, Yanagimachi M, Yamamoto M, Fukuda T, Miura O, Oba R, Igarashi A, Nagata Ok, Morio T. Utility of novel T-cell-specific extracellular vesicles in monitoring and analysis of acute GVHD. Int J Hematol. 2021;113(6):910–20.
Lim HC, Soneji S, Pálmason R, Lenhoff S, Laurell T, Scheding S. Improvement of acoustically remoted extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation. Biomark Res. 2021;9(1):6.
Kooijmans SAA, de Jong OG, Schiffelers RM. Exploring interactions between extracellular vesicles and cells for revolutionary drug supply system design. Adv Drug Deliv Rev. 2021;173:252–78.
Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Purposeful extracellular vesicles for regenerative drugs. Small 2022, 18 (36), e2106569.
Viswanathan S, Shi Y, Galipeau J, Krampera M, Leblanc Ok, Martin I, Nolta J, Phinney DG, Sensebe L. Mesenchymal stem versus stromal cells: worldwide society for cell & gene remedy (ISCT®) mesenchymal stromal cell committee place assertion on nomenclature. Cytotherapy. 2019;21(10):1019–24.
Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY. The which means, the sense and the importance: translating the science of mesenchymal stem cells into drugs. Nat Med. 2013;19(1):35–42.
Moll G, Ankrum JA, Kamhieh-Milz J, Bieback Ok, Ringdén O, Volk HD, Geissler S, Reinke P. Intravascular mesenchymal stromal/stem cell remedy product diversification: time for brand new scientific tips. Developments Mol Med. 2019;25(2):149–63.
Zhao L, Chen S, Yang P, Cao H, Li L. The position of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and remedy of graft-versus-host illness. Stem Cell Res Ther. 2019;10(1):182.
Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. MSC-derived exosomes: a novel instrument to deal with therapy-refractory graft-versus-host illness. Leukemia. 2014;28(4):970–3.
Hess NJ, Kink JA, Hematti P. Exosomes, MDSCs and Tregs: A brand new frontier for GVHD prevention and remedy. Entrance Immunol. 2023;14:1143381.
Lai P, Weng J, Guo L, Chen X, Du X. Novel insights into MSC-EVs remedy for immune ailments. Biomark Res. 2019;7:6.
Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for focused drug supply. Theranostics. 2021;11(7):3183–95.
Su Y, Solar X, Liu X, Qu Q, Yang L, Chen Q, Liu F, Li Y, Wang Q, Huang B, Huang XJ, Zhang XH. hUC-EVs-ATO scale back the severity of acute GVHD by resetting inflammatory macrophages towards the M2 phenotype. J Hematol Oncol. 2022;15(1):99.
Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L. Hematopoietic cell transplantation, model 2.2020, NCCN scientific observe tips in oncology. J Natl Compr Most cancers Community: JNCCN. 2020;18(5):599–634.
Iftikhar R, Chaudhry QUN, Anwer F, Neupane Ok, Rafae A, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, Khattak TA, Shamshad GU, Rehman J, Farhan M, Khan M, Ansar I, Ashraf R, Marsh J, Satti TM, Ahmed P. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: present indications and transplant methods. Blood Rev. 2021;47:100772.
Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China within the period of focused therapies: present advances, challenges, and future instructions. Lancet Haematol. 2022;9(12):e919–29.
Gratwohl A. Bone marrow transplantation exercise in Europe 1990. European group for bone marrow transplantation (EBMT). Bone Marrow Transplant. 1991;8(3):197–201.
Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Cámara R, Corbacioglu S, Dolstra H, Duarte R, Glass B, Greco R, Lankester AC, Mohty M, Peffault de Latour R, Snowden JA, Yakoub-Agha I, Kröger N. Hematopoietic cell transplantation and mobile remedy survey of the EBMT: monitoring of actions and developments over 30 years. Bone Marrow Transplant. 2021;56(7):1651–64.
Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, Giralt SA, LeMaistre CF, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, Veys PA, Carpenter PA, Hamadani M. Indications for hematopoietic cell transplantation and immune effector cell remedy: tips from the American society for transplantation and mobile remedy. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation. 2020;26(7):1247–56.
Passweg JR, Baldomero H, Ciceri F, Corbacioglu S, de la Cámara R, Dolstra H, Glass B, Greco R, McLornan DP, Neven B, de Latour RP, Perić Z, Ruggeri A, Snowden JA, Sureda A. Hematopoietic cell transplantation and mobile therapies in Europe 2021. The second 12 months of the SARS-CoV-2 pandemic. A report from the EBMT exercise survey. Bone Marrow Transplant. 2023;58(6):647–58.
[Chinese consensus. Of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host disease (2020)]. Zhonghua Xue ye Xue Za zhi = zhonghua Xueyexue Zazhi 2020, 41 (7), 529–36.
Xu LP, Lu PH, Wu DP, Solar ZM, Liu QF, Han MZ, Zhang X, Track YP, Track XM, Hu JD, Huang H, Lai YR, Wan DM, Chen J, Li CF, Xia LH, Wang JB, Liu DH, Huang XJ. Hematopoietic stem cell transplantation exercise in China 2019: a report from the Chinese language blood and marrow transplantation registry group. Bone Marrow Transplant. 2021;56(12):2940–7.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, Martin P, Chien J, Przepiorka D, Couriel D, Cowen EW, Dinndorf P, Farrell A, Hartzman R, Henslee-Downey J, Jacobsohn D, McDonald G, Mittleman B, Rizzo JD, Robinson M, Schubert M, Schultz Ok, Shulman H, Turner M, Vogelsang G, Flowers ME. Nationwide institutes of well being consensus growth undertaking on standards for scientific trials in continual graft-versus-host illness: I. Prognosis and staging working group report. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation. 2005;11(12):945–56.
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. Nationwide Institutes of Well being Consensus Improvement Mission on Standards for Medical Trials in Power Graft-versus-Host Illness: I. The 2014 Prognosis and Staging Working Group report. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 2015, 21 (3), 389–401.e1.
Koyama M, Hill GR. The primacy of Gastrointestinal tract antigen-presenting cells in deadly graft-versus-host illness. Blood. 2019;134(24):2139–48.
Hong C, Jin R, Dai X, Gao X. Purposeful contributions of antigen presenting cells in continual Graft-Versus-Host illness. Entrance Immunol. 2021;12:614183.
Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine continual graft-versus-host illness: necessities depend upon goal organ. Blood. 2005;105(5):2227–34.
Koyama M, Hill GR. Alloantigen presentation and graft-versus-host illness: gasoline for the hearth. Blood. 2016;127(24):2963–70.
Flowers ME, Martin PJ. How we deal with continual graft-versus-host illness. Blood. 2015;125(4):606–15.
Cutler CS, Koreth J, Ritz J. Mechanistic approaches for the prevention and remedy of continual GVHD. Blood. 2017;129(1):22–9.
Malard F, Mohty M. Updates in continual graft-versus-host illness administration. Am J Hematol. 2023;98(10):1637–44.
Hamilton BK. Updates in continual graft-versus-host illness. Hematol Am Soc Hematol Educ Program. 2021;2021(1):648–54.
Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, van den Brink MRM, Hansen JA, Parkman R, Miklos DB, Martin PJ, Paczesny S, Vogelsang G, Pavletic S, Ritz J, Schultz KR, Blazar BR. The biology of continual Graft-versus-Host illness: A process power report from the Nationwide institutes of well being consensus growth undertaking on standards for scientific trials in continual Graft-versus-Host illness. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation. 2017;23(2):211–34.
Greinix HT, Loddenkemper C, Pavletic SZ, Holler E, Socié G, Lawitschka A, Halter J, Wolff D. Prognosis and staging of continual graft-versus-host illness within the scientific observe. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation. 2011;17(2):167–75.
Welsh JA, Goberdhan DCI, O’Driscoll L, Buzas EI, Blenkiron C, Bussolati B, Cai H, Di Vizio D, Driedonks TAP, Erdbrügger U, Falcon-Perez JM, Fu QL, Hill AF, Lenassi M, Lim SK, Mahoney MG, Mohanty S, Möller A, Nieuwland R, Ochiya T, Sahoo S, Torrecilhas AC, Zheng L, Zijlstra A, Abuelreich S, Bagabas R, Bergese P, Bridges EM, Brucale M, Burger D, Carney RP, Cocucci E, Crescitelli R, Hanser E, Harris AL, Haughey NJ, Hendrix A, Ivanov AR, Jovanovic-Talisman T, Kruh-Garcia NA; Ku’ulei-Lyn, Faustino V, Kyburz D, Lässer C, Lennon KM, Lötvall J, Maddox AL, Martens-Uzunova ES, Mizenko RR, Newman LA, Ridolfi A, Rohde E, Rojalin T, Rowland A, Saftics A, Sandau US, Saugstad JA, Shekari F, Swift S, Ter-Ovanesyan D, Tosar JP, Useckaite Z, Valle F, Varga Z, van der Pol E, van Herwijnen MJC, Wauben MH. M.;, Wehman AM, Williams S, Zendrini A, Zimmerman AJ, Théry C, Witwer. Ok. W., Minimal info for research of extracellular vesicles (MISEV2023): From fundamental to superior approaches. Journal of extracellular vesicles 2024, 13 (2), e12404.
Cocozza F, Grisard E, Martin-Jaular L, Mathieu M, Théry C. SnapShot: extracellular vesicles. Cell. 2020;182(1):262–e2621.
Zhang M, Hu S, Liu L, Dang P, Liu Y, Solar Z, Qiao B, Wang C. Engineered exosomes from completely different sources for cancer-targeted remedy. Sign Transduct Goal Remedy. 2023;8(1):124.
Tang TT, Wang B, Li ZL, Wen Y, Feng ST, Wu M, Liu D, Cao JY, Yin Q, Yin D, Fu YQ, Gao YM, Ding ZY, Qian JY, Wu QL, Lv LL, Liu BC. Kim-1 focused extracellular vesicles: A brand new therapeutic platform for RNAi to deal with AKI. J Am Soc Nephrology: JASN. 2021;32(10):2467–83.
Wu P, Zhang B, Ocansey DKW, Xu W, Qian H. Extracellular vesicles: A vibrant star of nanomedicine. Biomaterials. 2021;269:120467.
Wang D, Jiang S, Zhang F, Ma S, C Heng B, Wang Y, Zhu J, Xu M, He Y, Wei Y, Zhang X, Xia X, Deng B. Cell membrane vesicles with enriched CXCR4 show enhances their focused supply as drug carriers to inflammatory websites. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2021;8(23):e2101562.
Xu S, Liu B, Fan J, Xue C, Lu Y, Li C, Cui D. Engineered mesenchymal stem cell-derived exosomes with excessive CXCR4 ranges for focused SiRNA gene remedy towards most cancers. Nanoscale. 2022;14(11):4098–113.
Hu Y, Li X, Zhang Q, Gu Z, Luo Y, Guo J, Wang X, Jing Y, Chen X, Su J. Exosome-guided bone focused supply of Antagomir-188 as an anabolic remedy for bone loss. Bioactive Mater. 2021;6(9):2905–13.
Luo H, Chen D, Li R, Li R, Teng Y, Cao Y, Zou X, Wang W, Zhou C. Genetically engineered CXCR4-modified exosomes for supply of miR-126 mimics to macrophages alleviate periodontitis. J Nanobiotechnol. 2023;21(1):116.
Stranford DM, Simons LM, Berman KE, Cheng L, DiBiase BN, Hung ME, Lucks JB, Hultquist JF, Leonard JN. Genetically encoding a number of functionalities into extracellular vesicles for the focused supply of biologics to T cells. Nat Biomedical Eng. 2024;8(4):397–414.
van Niel G, D’Angelo G, Raposo G. Shedding mild on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–28.
Wiklander OPB, Brennan M, Lötvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic purposes of extracellular vesicles. Sci Transl Med. 2019;11:492.
Sterzenbach U, Putz U, Low LH, Silke J, Tan SS, Howitt J. Engineered exosomes as autos for biologically lively proteins. Mol Remedy: J Am Soc Gene Remedy. 2017;25(6):1269–78.
Escudé M, de Castilla P, Tong L, Huang C, Sofias AM, Pastorin G, Chen X, Storm G, Schiffelers RM, Wang JW. Extracellular vesicles as a drug supply system: A scientific evaluate of preclinical research. Adv Drug Deliv Rev. 2021;175:113801.
Giaccone L, Faraci DG, Butera S, Lia G, Di Vito C, Gabrielli G, Cerrano M, Mariotti J, Dellacasa C, Felicetti F, Brignardello E, Mavilio D, Bruno B. Biomarkers for acute and continual graft versus host illness: state of the Artwork. Professional Rev Hematol. 2021;14(1):79–96.
Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: present know-how and scientific purposes. J Hematol Oncol. 2022;15(1):131.
Gavriilaki E, Sakellari I, Anyfanti P, Batsis I, Vardi A, Bousiou Z, Lazaridis A, Nikolaidou B, Zarifis I, Masmanidou M, Yiannaki E, Markala D, Anagnostopoulos A, Douma S, Gkaliagkousi E. Evaluation of endothelial damage and Professional-Coagulant exercise utilizing Circulating microvesicles in survivors of allogeneic hematopoietic cell transplantation. Int J Mol Sci. 2020;21:24.
ElGohary G, Toor AA, Gergis U. Engraftment syndrome after allogeneic stem cell transplantation: a scientific evaluate and meta-analysis. Bone Marrow Transplant. 2023;58(1):1–9.
Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(9):893–8.
Lia G, Brunello L, Bruno S, Carpanetto A, Omedè P, Festuccia M, Tosti L, Maffini E, Giaccone L, Arpinati M, Ciccone G, Boccadoro M, Evangelista A, Camussi G, Bruno B. Extracellular vesicles as potential biomarkers of acute graft-vs-host illness. Leukemia. 2018;32(3):765–73.
Lia G, Di Vito C, Bruno S, Tapparo M, Brunello L, Santoro A, Mariotti J, Bramanti S, Zaghi E, Calvi M, Comba L, Fascì M, Giaccone L, Camussi G, Boyle EM, Castagna L, Evangelista A, Mavilio D, Bruno B. Extracellular vesicles as biomarkers of acute Graft-vs.-Host illness after haploidentical stem cell transplantation and Publish-Transplant cyclophosphamide. Entrance Immunol. 2021;12:816231.
Baur R, Karl F, Böttcher-Loschinski R, Stoll A, Völkl S, Gießl A, Flamann C, Bruns H, Schlötzer-Schrehardt U, Böttcher M, Schewe DM, Fischer T, Jitschin R, Mackensen A, Mougiakakos D. Accumulation of T-cell-suppressive PD-L1(excessive) extracellular vesicles is related to GvHD and may affect GvL efficacy. J Immunother Most cancers 2023, 11 (3).
Łacina P, Crossland RE, Wielińska J, Czyż A, Szeremet A, Ussowicz M, Wróbel T, Dickinson AM, Bogunia-Kubik Ok. Differential expression of MiRNAs from extracellular vesicles in continual graft-versus-host illness: A preliminary research. Adv Clin Experimental Medication: Official Organ Wroclaw Med Univ. 2023;32(5):539–44.
Omer AK, Weisdorf DJ, Lazaryan A, Shanley R, Blazar BR, MacMillan ML, Brunstein C, Bejanyan N, Arora M. Late acute Graft-versus-Host illness after allogeneic hematopoietic stem cell transplantation. Biology Blood Marrow Transplantation: J Am Soc Blood Marrow Transplantation. 2016;22(5):879–83.
Yoshizawa S, Umezu T, Saitoh Y, Gotoh M, Akahane D, Kobayashi C, Ohyashiki JH, Ohyashiki Ok. Exosomal MiRNA signatures for Late-Onset acute Graft-Versus-Host illness in allogenic hematopoietic stem cell transplantation. Int J Mol Sci 2018, 19 (9).
Storci G, Barbato F, Ricci F, Tazzari PL, De Matteis S, Tomassini E, Dicataldo M, Laprovitera N, Arpinati M, Ursi M, Maffini E, Campanini E, Dan E, Manfroi S, Santi S, Ferracin M, Bonafe M, Bonifazi F. Pre-transplant CD69 + extracellular vesicles are negatively correlated with lively ATLG serum ranges and affiliate with the onset of GVHD in allogeneic HSCT sufferers. Entrance Immunol. 2022;13:1058739.
Liu H, Chen Y, Yin G, Xie Q. Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune ailments. Life Sci. 2021;277:119458.
Zhou T, He C, Lai P, Yang Z, Liu Y, Xu H, Lin X, Ni B, Ju R, Yi W, Liang L, Pei D, Egwuagu CE, Liu X. miR-204-containing exosomes ameliorate GVHD-associated dry eye illness. Sci Adv. 2022;8(2):eabj9617.
Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H, Tahara H, Takaori-Kondo A, Ichinohe T, Maekawa T. Graft-Versus-Host illness amelioration by human bone marrow mesenchymal stromal/stem cell-Derived extracellular vesicles is related to peripheral preservation of Naive T cell populations. Stem Cells. 2018;36(3):434–45.
Lai P, Chen X, Guo L, Wang Y, Liu X, Liu Y, Zhou T, Huang T, Geng S, Luo C, Huang X, Wu S, Ling W, Du X, He C, Weng J. A potent Immunomodulatory position of exosomes derived from mesenchymal stromal cells in stopping cGVHD. J Hematol Oncol. 2018;11(1):135.
Erratum to. Epidermal progress issue stimulates Exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 2023, 37 (7), e22990.
Zhu H, Lan L, Zhang Y, Chen Q, Zeng Y, Luo X, Ren J, Chen S, Xiao M, Lin Ok, Chen M, Li Q, Chen Y, Xu J, Zheng Z, Chen Z, Xie Y, Hu J, Yang T. Epidermal progress issue stimulates Exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2020;34(6):7372–86.
Amarnath S, Foley JE, Farthing DE, Gress RE, Laurence A, Eckhaus MA, Métais JY, Rose JJ, Hakim FT, Felizardo TC, Cheng AV, Robey PG, Stroncek DE, Sabatino M, Battiwalla M, Ito S, Fowler DH, Barrett AJ. Bone marrow-derived mesenchymal stromal cells Harness purinergenic signaling to tolerize human Th1 cells in vivo. Stem Cells. 2015;33(4):1200–12.
Norooznezhad AH, Yarani R, Payandeh M, Hoseinkhani Z, Kiani S, Taghizadeh E, Thakor AS, Mansouri Ok. Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for continual cutaneous graft-versus-host illness: A case report. J Cell Mol Med. 2022;26(2):588–92.
Zhang B, Yeo RWY, Lai RC, Sim EWK, Chin KC, Lim SK. Mesenchymal stromal cell exosome-enhanced regulatory T-cell manufacturing via an antigen-presenting cell-mediated pathway. Cytotherapy. 2018;20(5):687–96.
Liu W, Zhou N, Liu Y, Zhang W, Li X, Wang Y, Zheng R, Zhang Y. Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host illness through lowering the migration of donor T cells. Stem Cell Res Ther. 2021;12(1):153.
Wang L, Gu Z, Zhao X, Yang N, Wang F, Deng A, Zhao S, Luo L, Wei H, Guan L, Gao Z, Li Y, Wang L, Liu D, Gao C. Extracellular vesicles launched from human umbilical Wire-Derived mesenchymal stromal cells forestall Life-Threatening acute Graft-Versus-Host illness in a mouse mannequin of allogeneic hematopoietic stem cell transplantation. Stem Cells Dev. 2016;25(24):1874–83.
Li KL, Li JY, Xie GL, Ma XY. Exosomes launched from human bone Marrow-Derived mesenchymal stem cell attenuate acute Graft-Versus-Host illness after allogeneic hematopoietic stem cell transplantation in mice. Entrance Cell Dev Biology. 2021;9:617589.
Kelly Ok, Rasko JEJ. Mesenchymal stromal cells for the remedy of graft versus host illness. Entrance Immunol. 2021;12:761616.
Descalzi-Montoya DB, Yang Z, Fanning S, Hu W, LoMauro Ok, Zhao Y, Korngold R. Wire Blood-Derived multipotent stem cells ameliorate in vitro/in vivo alloreactive responses, and this impact is related to Exosomal microvesicles in vitro. Transplantation Cell Remedy. 2024;30(4):e3961–39614.
Li W, Si Y, Wang Y, Chen J, Huo X, Xu P, Jiang B, Li Z, Shang Ok, Luo Q, Xiong Y. hUCMSC-derived exosomes defend towards GVHD-induced Endoplasmic reticulum stress in CD4(+) T cells by focusing on the miR-16-5p/ATF6/CHOP axis. Int Immunopharmacol. 2024;135:112315.
Jiang Y, Zhao J, Wang M, Huang F, Li J, Liu R, Wan J, Hao S. Mesenchymal stem cell-derived exosomes can alleviate GVHD and protect the GVL impact in allogeneic stem cell transplantation animal fashions. Entrance Immunol. 2023;14:1284936.
Shafeghat Z, Dorfaki M, Dehrouyeh S, Arab FL, Roozbehani M, Falak R, Faraji F, Jafari R. Mesenchymal stem cell-derived exosomes for managing graft-versus-host illness: an up to date view. Transpl Immunol. 2023;81:101957.
Lightner AL, Fujiki M, Elshawy M, Dadgar N, Barnoski A, Osman M, Fulmer CG, Vaidya A. Mesenchymal stem cell extracellular vesicles as a brand new remedy paradigm in stable stomach organ transplantation: A case sequence. Stem Cells Dev. 2024;33(5–6):107–16.
Kavian N, Marut W, Servettaz A, Laude H, Nicco C, Chéreau C, Weill B, Batteux F. Arsenic trioxide prevents murine sclerodermatous graft-versus-host illness. J Immunol (Baltimore Md: 1950). 2012;188(10):5142–9.
Liu X, Su Y, Solar X, Fu H, Huang Q, Chen Q, Mo X, Lv M, Kong Y, Xu L, Huang X, Zhang X. Arsenic trioxide alleviates acute graft-versus-host illness by modulating macrophage polarization. Sci China Life Sci. 2020;63(11):1744–54.
An Ok, Xue MJ, Zhong JY, Yu SN, Lan TS, Qi ZQ, Xia JJ. Arsenic trioxide ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice by inducing CD4(+) T cell apoptosis. J Neuroinflamm. 2020;17(1):147.
Basso PJ, Gross sales-Campos H, Nardini V, Duarte-Silva M, Alves VBF, Bonfá G, Rodrigues CC, Ghirotto B, Chica JEL, Nomizo A, Cardoso CRB. Peroxisome Proliferator-Activated receptor alpha mediates the useful results of Atorvastatin in experimental colitis. Entrance Immunol. 2021;12:618365.
Li C, Zhang J, Wang W, Wang H, Zhang Y, Zhang Z. Arsenic trioxide improves Treg and Th17 stability by modulating STAT3 in treatment-naïve rheumatoid arthritis sufferers. Int Immunopharmacol. 2019;73:539–51.
Hamidou M, Néel A, Poupon J, Amoura Z, Ebbo M, Sibilia J, Viallard JF, Gaborit B, Volteau C, Hardouin JB, Hachulla E, Rieger F. Security and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label section IIa trial (Lupsenic). Arthritis Res Remedy. 2021;23(1):70.
Hong J, Fraebel J, Yang Y, Tkacyk E, Kitko C, Kim TK. Understanding and remedy of cutaneous graft-versus-host-disease. Bone Marrow Transplant. 2023;58(12):1298–313.
Yang H, Cheong S, He Y, Lu F. Mesenchymal stem cell-based remedy for autoimmune-related fibrotic pores and skin diseases-systemic sclerosis and sclerodermatous graft-versus-host illness. Stem Cell Res Ther. 2023;14(1):372.
Zhang Q, Fu L, Liang Y, Guo Z, Wang L, Ma C, Wang H. Exosomes originating from MSCs stimulated with TGF-β and IFN-γ promote Treg differentiation. J Cell Physiol. 2018;233(9):6832–40.
Wang J, Donohoe E, Canning A, Moosavizadeh S, Buckley F, Brennan M, Ryan AE, Ritter T. Immunomodulatory operate of licensed human bone marrow mesenchymal stromal cell-derived apoptotic our bodies. Int Immunopharmacol. 2023;125:111096. (Pt A).
Moll G, Ankrum JA, Olson SD, Nolta JA. Improved MSC minimal standards to maximise affected person security: A name to embrace tissue issue and hemocompatibility evaluation of MSC merchandise. Stem Cells Translational Med. 2022;11(1):2–13.
Moll G, Drzeniek N, Kamhieh-Milz J, Geissler S, Volk HD, Reinke P. MSC therapies for COVID-19: significance of affected person coagulopathy, thromboprophylaxis, cell product high quality and mode of supply for remedy security and efficacy. Entrance Immunol. 2020;11:1091.
Ringdén O, Moll G, Gustafsson B, Sadeghi B. Mesenchymal stromal cells for enhancing hematopoietic engraftment and remedy of Graft-Versus-Host illness, hemorrhages and acute respiratory misery syndrome. Entrance Immunol. 2022;13:839844.
Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lönnies H, Magnusson PU, Sanchez J, Teramura Y, Nilsson-Ekdahl Ok, Ringdén O, Korsgren O, Nilsson B, Le Blanc Ok. Are therapeutic human mesenchymal stromal cells appropriate with human blood? Stem Cells. 2012;30(7):1565–74.
Moll G, Ignatowicz L, Catar R, Luecht C, Sadeghi B, Hamad O, Jungebluth P, Dragun D, Schmidtchen A, Ringdén O. Completely different procoagulant exercise of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua. Stem Cells Dev. 2015;24(19):2269–79.
Burrello J, Caporali E, Gauthier LG, Pianezzi E, Balbi C, Rigamonti E, Bolis S, Lazzarini E, Biemmi V, Burrello A, Frigerio R, Martinetti G, Fusi-Schmidhauser T, Vassalli G, Ferrari E, Moccetti T, Gori A, Cretich M, Melli G, Monticone S, Barile L. Danger stratification of sufferers with SARS-CoV-2 by tissue issue expression in Circulating extracellular vesicles. Vascul Pharmacol. 2022;145:106999.
Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of extracellular vesicles. Adv Mater (Deerfield Seashore Fla) 2024, 36 (33), e2403199.
Chen J, Zheng M, Xiao Q, Wang H, Chi C, Lin T, Wang Y, Yi X, Zhu L. Current advances in Microfluidic-Primarily based extracellular vesicle evaluation. Micromachines 2024, 15 (5).
Solar Y, Shi H, Yin S, Ji C, Zhang X, Zhang B, Wu P, Shi Y, Mao F, Yan Y, Xu W, Qian H. Human mesenchymal stem cell derived exosomes alleviate kind 2 diabetes mellitus by reversing peripheral insulin resistance and relieving β-Cell destruction. ACS Nano. 2018;12(8):7613–28.
Yang C, Solar J, Tian Y, Li H, Zhang L, Yang J, Wang J, Zhang J, Yan S, Xu D. Immunomodulatory impact of MSCs and MSCs-Derived extracellular vesicles in systemic lupus erythematosus. Entrance Immunol. 2021;12:714832.
You DG, Lim GT, Kwon S, Um W, Oh BH, Track SH, Lee J, Jo DG, Cho YW, Park JH. Metabolically engineered stem cell-derived exosomes to manage macrophage heterogeneity in rheumatoid arthritis. Sci Adv. 2021;7:23.
Weng Z, Zhang B, Wu C, Yu F, Han B, Li B, Li L. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in most cancers. J Hematol Oncol. 2021;14(1):136.
Riazifar M, Mohammadi MR, Pone EJ, Yeri A, Lässer C, Segaliny AI, McIntyre LL, Shelke GV, Hutchins E, Hamamoto A, Calle EN, Crescitelli R, Liao W, Pham V, Yin Y, Jayaraman J, Lakey JRT, Walsh CM, Van Keuren-Jensen Ok, Lotvall J, Zhao W. Stem Cell-Derived exosomes as nanotherapeutics for autoimmune and neurodegenerative issues. ACS Nano. 2019;13(6):6670–88.
Gupta M, Tieu A, Slobodian M, Shorr R, Burger D, Lalu MM, Allan DS. Preclinical research of MSC-Derived extracellular vesicles to deal with or forestall graft versus host illness: a scientific evaluate of the literature. Stem Cell Opinions Rep. 2021;17(2):332–40.
Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Synthetic exosomes for translational nanomedicine. J Nanobiotechnol. 2021;19(1):242.
Madel RJ, Börger V, Dittrich R, Bremer M, Tertel T, Phuong NNT, Baba HA, Kordelas L, Staubach S, Stein F, Haberkant P, Hackl M, Grillari R, Grillari J, Buer J, Horn PA, Westendorf AM, Brandau S, Kirschning CJ, Giebel B. Impartial human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate signs in a complicated murine graft-versus-host illness mannequin. Cytotherapy. 2023;25(8):821–36.
Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of extracellular vesicles. Adv Mater (Deerfield Seashore Fla) 2024, e2403199.
Li Q, Li B, Chen Z, Xu W, Yin H, Deng Z, Li H, Yan X, Hao X, Li L, Tao Z, Liu B, Ye T, Luo L, Qian H, Fu Q-L, Wang Q, Zheng L, Wang Y. Necessities for human pluripotent stem cell derived small extracellular vesicles. Interdisciplinary Med 2023, 1 (2), e20220018.
Li Q, Li B, Ye T, Xu W, Yin H, Deng Z, Li H, Yan X, Hao X, Li L, Tao Z, Liu B, Chen Z, Luo L, Qian H, Fu Q-L, Wang Q, Zheng L, Wang Y. Necessities for human mesenchymal stem cell-derived small extracellular vesicles. Interdisciplinary Med 2023, 1 (1), e20220015.
